• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建一种新型与二硫键相关的 lncRNA 预后标志物用于胰腺癌。

Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer.

机构信息

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Mol Biotechnol. 2024 Sep;66(9):2396-2414. doi: 10.1007/s12033-023-00875-z. Epub 2023 Sep 21.

DOI:10.1007/s12033-023-00875-z
PMID:37733182
Abstract

Pancreatic cancer is a lethal, extremely aggressive gastrointestinal tumor with a poor prognosis and limited treatment alternatives. Disulfidptosis is a newly defined type of cell death with potential influence on cancer. Research on the association between disulfidptosis and pancreatic cancer is scarce. The expression data of disulfidptosis-related genes were downloaded from The Cancer Genome Atlas-Pancreatic Adenocarcinoma (TCGA). Disulfidptosis-related lncRNA signature (DRLS) was developed through the Cox and the least absolute shrinkage and selection operator (LASSO) analysis. Differences in enrichment functions, mutational landscape, immune microenvironment, and predicted therapeutic efficacy between high- and low-risk groups were assessed. Consensus clustering analysis was applied to identify the DRLS-related subtypes. Among 98 disulfidptosis-related lncRNAs, 5 lncRNAs were screened thus constructing a prognostic DRLS. DRLS showed high predictive accuracy and was an independent prognostic factor for pancreatic cancer. According to the risk scores calculated from the signature, samples were categorized into high- and low- risk groups. Overall, low-risk patients had a better prognosis, lower mutational occurrences, higher immune cell infiltration and more sensitivity to anti-tumor agents. The DRLS performed well in predicting prognosis and revealed intimate correlation with biological function, mutation status and immune infiltration landscape of pancreatic cancer, providing some insights for future research on the relationship between disulfidptosis and pancreatic cancer.

摘要

胰腺癌是一种致命的、极具侵袭性的胃肠道肿瘤,预后不良,治疗选择有限。二硫键凋亡是一种新定义的细胞死亡类型,可能对癌症有影响。关于二硫键凋亡与胰腺癌之间的关系的研究还很少。从癌症基因组图谱-胰腺腺癌(TCGA)下载了与二硫键凋亡相关的基因表达数据。通过 Cox 和最小绝对收缩和选择算子(LASSO)分析,开发了与二硫键凋亡相关的长非编码 RNA 特征(DRLS)。评估了高低风险组之间的富集功能、突变景观、免疫微环境和预测治疗效果的差异。应用共识聚类分析来识别 DRLS 相关的亚型。在 98 个与二硫键凋亡相关的长非编码 RNA 中,筛选出 5 个长非编码 RNA,从而构建了一个预后 DRLS。DRLS 显示出较高的预测准确性,是胰腺癌的独立预后因素。根据该特征计算的风险评分,样本被分为高风险组和低风险组。总的来说,低风险患者的预后更好,突变发生率更低,免疫细胞浸润更高,对抗肿瘤药物更敏感。DRLS 在预测预后方面表现良好,并与胰腺癌的生物学功能、突变状态和免疫浸润景观密切相关,为进一步研究二硫键凋亡与胰腺癌之间的关系提供了一些思路。

相似文献

1
Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer.构建一种新型与二硫键相关的 lncRNA 预后标志物用于胰腺癌。
Mol Biotechnol. 2024 Sep;66(9):2396-2414. doi: 10.1007/s12033-023-00875-z. Epub 2023 Sep 21.
2
Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.构建并验证结肠癌中与二硫键错配相关的 lncRNAs 特征用于亚型、预后和免疫图谱分析
Int J Mol Sci. 2023 Aug 18;24(16):12915. doi: 10.3390/ijms241612915.
3
Development and validation of a novel disulfidptosis-related lncRNAs signature in patients with HPV-negative oral squamous cell carcinoma.一种新型与二硫键相关的 lncRNAs 标志物在 HPV 阴性口腔鳞状细胞癌患者中的开发和验证。
Sci Rep. 2024 Jun 23;14(1):14436. doi: 10.1038/s41598-024-65194-y.
4
Unlocking the Potential of Disulfidptosis-Related LncRNAs in Lung Adenocarcinoma: A Promising Prognostic LncRNA Model for Survival and Immunotherapy Prediction.解锁肺腺癌中与二硫键相关的长链非编码 RNA 的潜力:一个有前途的用于生存和免疫治疗预测的长链非编码 RNA 模型。
Cancer Med. 2024 Oct;13(20):e70337. doi: 10.1002/cam4.70337.
5
Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.开发一种新型的与二硫键错配相关的 lncRNA 标志物,用于预测透明细胞肾细胞癌的预后和免疫反应。
Sci Rep. 2024 Jan 5;14(1):624. doi: 10.1038/s41598-024-51197-2.
6
Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma.二硫键相关 lncRNAs 特征预测肺腺癌的预后和免疫治疗效果。
Aging (Albany NY). 2024 Jun 10;16(11):9972-9989. doi: 10.18632/aging.205911.
7
Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer.胃癌分子分类、免疫微环境特征及预后中与二硫化物诱导细胞死亡相关长链非编码RNA的综合分析
Biomedicines. 2023 Nov 28;11(12):3165. doi: 10.3390/biomedicines11123165.
8
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.生物信息学分析利用了九个免疫相关的长非编码 RNA 特征作为胰腺癌的预后靶点。
J Cell Biochem. 2019 Sep;120(9):14916-14927. doi: 10.1002/jcb.28754. Epub 2019 Apr 23.
9
Construction and validation of a prognostic model for bladder cancer based on disulfidptosis-related lncRNAs.基于二硫键相关 lncRNAs 的膀胱癌预后模型的构建与验证。
Medicine (Baltimore). 2024 Jul 5;103(27):e38750. doi: 10.1097/MD.0000000000038750.
10
A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer.一种与二硫键相关的长非编码 RNA 指数可预测结直肠癌的预后和肿瘤微环境。
Sci Rep. 2023 Nov 16;13(1):20135. doi: 10.1038/s41598-023-47472-3.

引用本文的文献

1
Disulfidptosis in tumor progression.肿瘤进展中的二硫化物诱导细胞死亡
Cell Death Discov. 2025 Apr 28;11(1):205. doi: 10.1038/s41420-025-02495-9.
2
Based on disulfidptosis, unveiling the prognostic and immunological signatures of Asian hepatocellular carcinoma and identifying the potential therapeutic target ZNF337-AS1.基于二硫化物诱导的细胞程序性坏死,揭示亚洲肝细胞癌的预后和免疫特征并确定潜在治疗靶点ZNF337-AS1。
Discov Oncol. 2025 Apr 17;16(1):544. doi: 10.1007/s12672-025-02325-5.
3
Comprehensive identification of a disulfidptosis-associated long non-coding RNA signature to predict the prognosis and treatment options in ovarian cancer.

本文引用的文献

1
A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma.一种基于 HOXA10 相关的 5 个基因的新型预后标志物,用于分层胰腺导管腺癌的短期生存者。
Clin Cancer Res. 2023 Sep 15;29(18):3759-3770. doi: 10.1158/1078-0432.CCR-23-0825.
2
An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma.基于二硫键介导的铁死亡相关预后特征及透明细胞肾细胞癌不同亚型的综合多组学分析
Front Oncol. 2023 Jun 23;13:1207068. doi: 10.3389/fonc.2023.1207068. eCollection 2023.
3
全面鉴定与二硫键错配相关的长非编码 RNA 特征,以预测卵巢癌的预后和治疗选择。
Front Endocrinol (Lausanne). 2024 Sep 13;15:1434705. doi: 10.3389/fendo.2024.1434705. eCollection 2024.
4
Disulfidptosis-related lncRNA signature reveals immune microenvironment and novel molecular subtyping of stomach adenocarcinoma.二硫化物诱导细胞程序性坏死相关lncRNA特征揭示胃腺癌的免疫微环境及新分子亚型
Heliyon. 2024 Apr 9;10(8):e29005. doi: 10.1016/j.heliyon.2024.e29005. eCollection 2024 Apr 30.
5
Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.开发一种新型的与二硫键错配相关的 lncRNA 标志物,用于预测透明细胞肾细胞癌的预后和免疫反应。
Sci Rep. 2024 Jan 5;14(1):624. doi: 10.1038/s41598-024-51197-2.
Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
基于二硫键凋亡相关基因的新型分子分类鉴定及其在肝细胞癌中的预后和免疫治疗疗效预测
Aging (Albany NY). 2023 Jul 3;15(13):6135-6151. doi: 10.18632/aging.204809.
4
Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer.通过综合分析和实验验证在胰腺癌中鉴定与化疗耐药相关的预后基因特征
Front Oncol. 2023 May 12;13:1132424. doi: 10.3389/fonc.2023.1132424. eCollection 2023.
5
Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853.系统分析胰腺癌中铜死亡相关 lncRNAs,重点探讨 LINC00853 的分子机制。
Int J Mol Sci. 2023 Apr 27;24(9):7923. doi: 10.3390/ijms24097923.
6
Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer.铜死亡相关 lncRNA 特征分析用于预测胰腺癌的预后和肿瘤免疫微环境。
Apoptosis. 2023 Aug;28(7-8):1090-1112. doi: 10.1007/s10495-023-01843-3. Epub 2023 Apr 20.
7
Accelerating the understanding of cancer biology through the lens of genomics.通过基因组学视角加速癌症生物学的理解。
Cell. 2023 Apr 13;186(8):1755-1771. doi: 10.1016/j.cell.2023.02.015.
8
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.单细胞分析探索胰腺癌异质性、可塑性和对治疗的反应。
Nat Cancer. 2023 Apr;4(4):454-467. doi: 10.1038/s43018-023-00526-x. Epub 2023 Mar 23.
9
Patient-centered outcomes in the POLO study of active maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.POLO研究中关于奥拉帕利用于胚系BRCA突变的转移性胰腺癌主动维持治疗的以患者为中心的结局
Cancer. 2023 May 1;129(9):1411-1418. doi: 10.1002/cncr.34610. Epub 2023 Feb 22.
10
Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.细胞骨架对二硫键压力的脆弱性介导了二硫键细胞凋亡。
Nat Cell Biol. 2023 Mar;25(3):404-414. doi: 10.1038/s41556-023-01091-2. Epub 2023 Feb 6.